DURHAM, N.C., March 10, 2011 (GLOBE NEWSWIRE) -- Patrick S. Smith, President and Chief Executive Officer of Curaxis Pharmaceutical Corp. (OTCQB:CURX) (Frankfurt: 8CX), commented today on an article by Duff Wilson published in the New York Times on March 6, 2011. According to Mr. Smith, the article titled "Drug Firms Face Billions in Losses in '11 as Patents End," which discusses the rationale for investing in Big Pharma while patents are expiring and drug pipelines are virtually empty, can be viewed as positive news for Curaxis.
